During the data period, approximately 18.6 million Nexium prescriptions were written. Nexium came close on the heels of hypothyroidism drug levothyroxine (22.6 million prescriptions) and cholesterol-lowering drug Crestor (22.5 million prescriptions).
Nexium netted $6.3 billion in sales, tied with Humira for the second top-selling drug during the data period. Notably, hepatitis C drug Sovaldi generated $4.4 billion in sales.
More Articles on Gastroenterology:
Endoscopy device market to reach $36.9B in 2019
7 gastroenterologists making the news
Young gastroenterologists: the essential skills to thrive in healthcare today
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
